News & Media

Take a closer look at what we’re doing across Teva worldwide

Top Stories

Read the latest Teva news.


Life changing Migraine Treatment to be listed on PBS



New PBS listing of AJOVY® to address significant unmet need in adults with chronic migraine



Our ESG Progress: Four Employee Perspectives



Coronavirus (COVID-19) Teva Australia



Update Regarding COVID-19



New preventive treatment for migraine now licensed in Australia



Teva Australia Launches new Brand



Teva Signs New $2.3 Billion Syndicated Revolving Credit Facility



Moving at light speed



2017 Annual Report

Media Inquiries

Contact Teva Corporate Communications.

Learn more Media Inquiries
Hand writing in a notebook

Financial Reports

View Teva financial news on our global website.

Learn more Financial Reports
Hands holding coffee mug

Contact us

You can contact us at any time with your questions or remarks.

Read more Contact us